SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
A Comparison of Reimbursement Recommendations by European HTA Agencies: Is There Opportunity for Further Alignment?
3 references·2 citing·22 second hop
A Comparison of Reimbursement Recommendations by European HTA Agencies: Is There Opportunity for Further Alignment? (2017)A Comparison of Reimbursement Recommendat…Early benefit assessment (EBA) in Germany: analysing decisions 18 months after introducing the new AMNOG legislation (2013)Early benefit assessment (EBA…Commonalities and differences in HTA outcomes: A comparative analysis of five countries and implications for coverage decisions (2012)Commonalities and differences…Key principles for the improved conduct of health technology assessments for resource allocation decisions (2008)Key principles for the improv…Use of External Comparators for Health Technology Assessment Submissions Based on Single-Arm Trials (2021)Use of External Comparators f…Differences in Health Technology Assessment Recommendations Among European Jurisdictions: The Role of Practice Variations (2020)Differences in Health Technol…WORLD HEALTH ORGANISATION (1957)A Coefficient of Agreement for Nominal Scales (1960)Health Technology Assessment (HTA) Case Studies: Factors Influencing Divergent HTA Reimbursement Recommendations in Australia, Canada, England, and Scotland (2016)HTA Implementation Roadmap in Central and Eastern European Countries (2016)Why do health technology assessment coverage recommendations for the same drugs differ across settings? Applying a mixed methods framework to systematically compare orphan drug decisions in four European countries (2016)Cost-Effectiveness in Health and Medicine (1996)Methods for the Economic Evaluation of Health Care Programmes (2005)Methods for the economic evaluation of health care programmes, 3rd ed (2006)Consolidated Health Economic Evaluation Reporting Standards (CHEERS) statement (2013)Consolidated Health Economic Evaluation Reporting Standards (CHEERS) statement (2013)Consolidated Health Economic Evaluation Reporting Standards (CHEERS)—Explanation and Elaboration: A Report of the ISPOR Health Economic Evaluation Publication Guidelines Good Reporting Practices Task Force (2013)Interrater reliability: the kappa statistic (2012)The Influence of Cost‐Effectiveness and Other Factors on Nice Decisions (2014)Variation in Health Technology Assessment and Reimbursement Processes in Europe (2016)Application of Managed Entry Agreements for Innovative Therapies in Different Settings and Combinations: A Feasibility Analysis (2020)The results of direct and indirect treatment comparisons in meta-analysis of randomized controlled trials (1997)Conducting Indirect-Treatment-Comparison and Network-Meta-Analysis Studies: Report of the ISPOR Task Force on Indirect Treatment Comparisons Good Research Practices: Part 2 (2011)Methods for Population-Adjusted Indirect Comparisons in Health Technology Appraisal (2017)Real-world data: a comprehensive literature review on the barriers, challenges, and opportunities associated with their inclusion in the health technology assessment process (2024)De innovatione: The concept of innovation for medical technologies and its implications for healthcare policy-making (2015)Health benefit assessment of pharmaceuticals: An international comparison of decisions from Germany, England, Scotland and Australia (2016)Value and Price of Multi-indication Cancer Drugs in the USA, Germany, France, England, Canada, Australia, and Scotland (2022)
this work references cited by second hop

References

  • 2008Key principles for the improved conduct of health technology assessments for resource allocation decisions489 cited
  • 2012Commonalities and differences in HTA outcomes: A comparative analysis of five countries and implications for coverage decisions93 cited
  • 2013Early benefit assessment (EBA) in Germany: analysing decisions 18 months after introducing the new AMNOG legislation90 cited

Cited by

  • 2021Use of External Comparators for Health Technology Assessment Submissions Based on Single-Arm Trials74 cited
  • 2020Differences in Health Technology Assessment Recommendations Among European Jurisdictions: The Role of Practice Variations64 cited

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work